Trial intelligence / Profile preview

Short-course radiotherapy plus neoadjuvant XELOX and total mesorectal excision in MRI-defined high-risk rectal cancer (Phase II)

KCT0003367Phase 2Completed

Sponsor

Boryung

Start

Jan 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1